James M. Gower
2009
In 2009, James M. Gower earned a total compensation of $2M as Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $504,000 |
|---|---|
| Option Awards | $890,682 |
| Salary | $600,000 |
| Other | $3,564 |
| Total | $1,998,246 |
Gower received $890.7K in option awards, accounting for 45% of the total pay in 2009.
Gower also received $504K in non-equity incentive plan, $600K in salary and $3.6K in other compensation.
Rankings
In 2009, James M. Gower's compensation ranked 2,377th out of 9,885 executives tracked by ExecPay. In other words, Gower earned more than 76.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,377 out of 9,885 | 76th |
Division Manufacturing | 832 out of 3,690 | 78th |
Major group Chemicals And Allied Products | 162 out of 871 | 81st |
Industry group Drugs | 96 out of 643 | 85th |
Industry Pharmaceutical Preparations | 76 out of 446 | 83rd |
Source: SEC filing on April 12, 2012.
Gower's colleagues
We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2009.
2009
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2009
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2009
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2009
Ryan Maynard
Rigel Pharmaceuticals